Identification of Retevmo:

No description

Search images on Google      Product Monograph

Active Ingredients:

• selpercatinib, 40 MG

DIN: 02516918

Dosage Form(s): CAPSULE

Route(s) of Administration: ORAL

Schedule: Prescription

Company: LOXO ONCOLOGY INC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01E - (ATC, WHO)
• L01EX - (ATC, WHO)
• L01EX22 - SELPERCATINIB (WHO)

 

External Links for Retevmo:

Search on Google

• Retevmo side effects
• Retevmo dosage
• selpercatinib side effects
• selpercatinib dosage